iDEL Therapeutics
Munich, Germany· Est.
Focuses on developing intracellular drug delivery platforms for targeted protein degradation and other therapeutic modalities.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
Focuses on developing intracellular drug delivery platforms for targeted protein degradation and other therapeutic modalities.
Drug DeliveryOncology